We’ve received many questions from APT Webstudy participants about the availability of Alzheimer’s blood biomarker tests. Your continued participation in the APT Webstudy may lead to an invitation to take one of these tests or join a clinical trial. To learn more, join Dr. Reisa Sperling, a world-renowned Alzheimer’s expert, and Carol Turner, an Alzheimer's clinical trial participant and advocate, for the next Alzheimer Prevention Talk. Dr. Sperling and Ms. Turner will share how participation in the APT Webstudy can lead to an invitation to access these blood tests and how APT participation has spurred clinical trial recruitment.
Dr. Sperling and Ms. Turner will discuss: • How participation in the APT Webstudy can lead to further testing and possible Alzheimer’s clinical trial opportunities; • How Alzheimer’s blood tests are used in clinical trials research; • Examples of how the APT Webstudy has contributed to scientific developments in Alzheimer’s research; and more.
When:
Thursday, September 25, 2025 5:30-6:15pm ET / 2:30-3:15pm PT